SCHEMBL16740189

SCHEMBL16740189

CC(C)CC(C)N(CC(CN(c1ccc(Nc2ccccc2)cc1)C(C)CC(C)C)OCCCc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)c1ccc(Nc2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPK1 P28482 3/20 0.32
ALDH1A1 P00352 3/20 0.32
ALOX15 P16050 2/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
ALOX12 P18054 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
SCN2A Q99250 2/20 0.32
MAPT P10636 2/20 0.31
MCL1 Q07820 2/20 0.31
PLEC Q15149 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 1/20 0.31
AGTR1 P30556 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20171343 0.84 GAA (0.39) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL2741266 0.82 GAA (0.43) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL2741264 0.82 GAA (0.43) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL2741286 0.82 GAA (0.43) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL16740190 0.80 GAA (0.33) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL16740194 0.79 GAA (0.33) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL18109164 0.79 GAA (0.33) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL14963224 0.76 GAA (0.40) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL2741295 0.76 GAA (0.37) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL14963225 0.76 GAA (0.40) GAAMEN1KMT2AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3071544-B1 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES METHODS OF MAKING AND USING THE SAME POLNOX CORP (US) 2022-07-06 EP disclosed
US-11060027-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same POLNOX CORPORATION (US) 2021-07-13 US disclosed
US-20200392406-A1 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES, METHODS OF MAKING AND USING THE SAME POLNOX CORPORATION 2020-12-17 US disclosed
US-10683455-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same POLNOX CORPORATION (US) 2020-06-16 US disclosed
US-20190292454-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same POLNOX CORPORATION 2019-09-26 US disclosed
US-10294423-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same POLNOX CORPORATION (US) 2019-05-21 US disclosed
US-20160289558-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same POLNOX CORPORATION (US) 2016-10-06 US disclosed
EP-3071544-A2 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES METHODS OF MAKING AND USING THE SAME Polnox Corporation (US) 2016-09-28 EP disclosed
WO-2015077635-A2 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES METHODS OF MAKING AND USING THE SAME POLNOX CORPORATION (US) 2015-05-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11060027-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same LPO, GPX4, DUOX2 GAA 1034/4885MEN1 4348/4885KMT2A 3358/4885
US-10683455-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same LPO, GPX4, DUOX2 GAA 1034/4885MEN1 4348/4885KMT2A 3358/4885
US-20160289558-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same LPO, GPX4, DUOX2 GAA 1016/4885MEN1 4123/4885KMT2A 3409/4885
US-20190292454-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same LPO, GPX4, DUOX2 GAA 1034/4885MEN1 4348/4885KMT2A 3358/4885
US-20200392406-A1 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES, METHODS OF MAKING AND USING THE SAME LPO, GPX4, DUOX2 GAA 1034/4885MEN1 4348/4885KMT2A 3358/4885
US-10294423-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same LPO, GPX4, DUOX2 GAA 1016/4885MEN1 4123/4885KMT2A 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.